In vitro pre- and post-exposure prophylaxis using HIV inhibitors as microbicides against cell-free or cell-associated HIV-1 infection.
about
Human immunodeficiency virus type 1 resistance or cross-resistance to nonnucleoside reverse transcriptase inhibitors currently under development as microbicides.Vaginal microbicide gel for delivery of IQP-0528, a pyrimidinedione analog with a dual mechanism of action against HIV-1.In vitro activities of candidate microbicides against cell-associated HIVHuman immunodeficiency virus type 1 (HIV-1) integration: a potential target for microbicides to prevent cell-free or cell-associated HIV-1 infection.Inhibition of human immunodeficiency virus type 1 infection by the candidate microbicide dapivirine, a nonnucleoside reverse transcriptase inhibitorAn African perspective on mucosal immunity and HIV-1.Pharmaceutical development of microbicide drug products.HIV sexual transmission and microbicides.Design of a semisolid vaginal microbicide gel by relating composition to properties and performance.Optimization (central composite design) and validation of HPLC method for investigation of emtricitabine loaded poly(lactic-co-glycolic acid) nanoparticles: in vitro drug release and in vivo pharmacokinetic studies.Polymeric Nanoparticles Affect the Intracellular Delivery, Antiretroviral Activity and Cytotoxicity of the Microbicide Drug Candidate DapivirineHigh-Performance Liquid Chromatographic Method for Analysis of Emtricitabine in Rat Plasma: Method Development, Validation and Application to a Pharmacokinetic Study
P2860
Q34737547-EDA8ADA4-A491-4676-A547-336ED21C066EQ34737582-5C7727D6-5F06-4035-B323-8605FEA7CFA6Q35689194-A4AD2D6E-346B-4F45-89D3-50D269032C5BQ36744775-0E550646-3F69-4B40-9694-AA483D100C9AQ37072072-9D33E8FD-57E4-4964-9A0D-FAB0F10E9272Q37472898-FBBC15E9-F16C-4FF0-8D52-774FC4E90B12Q37657468-468EAA2F-DE7C-4E8A-9506-BDC71F1325A4Q37853935-6E13BACC-ADA7-4287-BE49-9994D47246B3Q51661044-CFB92E1C-301D-4AB5-904D-A8F84FA02925Q55170368-5D8C55C4-8295-4EF7-B0C5-3757378A47EDQ57570872-4493444D-09BC-4D30-8BA7-842D4AA924F3Q58994217-BBFA2E5C-5B22-479A-9279-30D35EE10E4D
P2860
In vitro pre- and post-exposure prophylaxis using HIV inhibitors as microbicides against cell-free or cell-associated HIV-1 infection.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
In vitro pre- and post-exposur ...... ll-associated HIV-1 infection.
@en
In vitro pre- and post-exposur ...... ll-associated HIV-1 infection.
@nl
type
label
In vitro pre- and post-exposur ...... ll-associated HIV-1 infection.
@en
In vitro pre- and post-exposur ...... ll-associated HIV-1 infection.
@nl
prefLabel
In vitro pre- and post-exposur ...... ll-associated HIV-1 infection.
@en
In vitro pre- and post-exposur ...... ll-associated HIV-1 infection.
@nl
P2093
P2860
P1476
In vitro pre- and post-exposur ...... ll-associated HIV-1 infection.
@en
P2093
Guido Vanham
Jens Van Roey
Katty Terrazas-Aranda
Paul J Lewi
Yven Van Herrewege
P2860
P304
P356
10.1177/095632020701800304
P577
2007-01-01T00:00:00Z